Grail
GRAL
132.90
-4.38
-3.19%
Grail
US · GRAL
#1873 by market cap
Listed 2024
132.90
-4.38
-3.19%
Live - 5344 symbols - heartbeat 244s ago
· 2026-10-08 07:00
Pre-market
131.82
-0.81%
After-hours
132.70
-0.15%
Overnight
131.00
-1.43%
- Market cap
- 5.94B
- P/E (TTM)i
- -13.72
- P/Bi
- 2.33
- EPSi
- -11.11
- Div yieldi
- 0.00%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on GRAL?
Anonymous reader poll. Unscientific, not investment advice.
About Grail
GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.
- Founded
- 2015
- CEO
- Mr. Robert Ragusa
- Employees
- 910
- Headquarters
- Menlo Park, California, United States of America
- Fiscal year end
- 12-31
- Website
- grail.com
Company profile
- Exchange
- US
- Symbol
- GRAL
- Market-cap rank
- #1873
- Listing date
- 2024-06-12
- Market cap
- 5.94B
- Float cap
- 4.56B
- Shares out
- 44.67M
- Float shares
- 34.34M
Sectors & themes
Diagnostics & Research
Fractional Shares JP
Quote time 2026-10-08 07:00:09 · For reference only, not investment advice and not tailored to your situation.